Develops rapid tests that analyze the immune system to diagnose acute infections and sepsis.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Their initial focus is on acute bacterial and viral infections, and sepsis.
Inflammatix Funding
Sign up to gain insights into Inflammatix funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series E | Sep 12, 2024 | 45M | ||
| Series E | Sep 12, 2024 | 12M | ||
| Series E | Sep 12, 2024 | 49M | ||
| Series D | Mar 15, 2021 | 102M | ||
| Series C | Jan 09, 2020 | 32M | ||
| Series B | Oct 18, 2018 | 14M | ||
| Series A | Feb 17, 2017 | 4M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Inflammatix Management Team
Investors
Think.Health Ventures
OSF Healthcare
Northpond Ventures
Khosla Ventures
Grey Sky Venture Partners
D1 Capital Partners
Inflammatix Valuations & Financials
View real-time NPM data on Inflammatix stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Inflammatix
Cityblock Health
Health Care
Tech-driven care provider for communities with complex needs.
Benchling
Health Care
Cloud based platform for research and development in biotechnology.
Lyra
Health Care
Digital health startup using technology to connect companies and employees to mental health providers.
Eikon Therapeutics
Health Care
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Somatus
Health Care
Integrated care for patients with or at risk of developing kidney disease.
Tonal
Health Care
Delivers AI-powered strength training with digital weights and personalized coaching.
Devoted
Health Care
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
FAQ
We have answers
Inflammatix stock does not trade on public stock exchanges. Inflammatix stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Inflammatix stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Inflammatix Stock does not trade on public stock exchanges. In order to sell Inflammatix shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Inflammatix does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Inflammatix share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Inflammatix stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Inflammatix stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Inflammatix stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Inflammatix is a private company and has not had an IPO. There is currently no Inflammatix IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Inflammatix IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
